Do Evidence Review Groups Bias NICE Decisions?

ERGs are independent academic organizations commissioned by NICE to act objectively, but how much influence do they have on reimbursement decisions and cost-effectiveness assessments?

Our webinar explores the potential bias and policy / industry implications:

  • If ERGs are supposed to be independent and objective, will there be differences among the groups?
  • Do ERGs cover different therapeutic areas?
  • Are there different rates of positive decisions between the ERGs?
  • Are some ERGs more critical of the economic evidence?